Vanda Pharmaceuticals Inc. (VNDA)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
D E Shaw

D. E. Shaw

2,112,125 $8,913,168 +9% 0%
2.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

1,013,251 $4,275,919 +2% 0.25%
3.
Millennium Management

Israel Englander

998,292 $4,212,792 -51% 0%
4.
Two Sigma Advisors

John Overdeck And David Siegel

886,500 $3,741,030 +16% 0%
5. 619,006 $2,612,205 -10% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$8.97 3,239 Large Shareholder, Other 1,103,617 2015-12-16 Filing
$8.97 4,441 Large Shareholder, Other 2,740,122 2015-12-16 Filing
$8.97 3,490 Large Shareholder, Other 2,152,952 2015-12-16 Filing
$8.61 93,634 Large Shareholder, Other 1,100,378 2015-12-11 Filing
$8.61 128,374 Large Shareholder, Other 2,735,681 2015-12-11 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$4.18 8,941 196,825 2024-03-05 Filing
$4.41 8,147 205,766 2024-03-04 Filing
$4.21 9,229 129,789 2024-03-05 Filing
$4.41 7,498 139,018 2024-03-04 Filing
$4.13 24,288 1,871,730 2024-03-05 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 8,346,367 $35,221,670 0%
2. 3,456,087 $14,584,687 0%
3. 2,022,968 $8,536,923 0%
4. 1,967,985 $8,305,054 0%
5. 1,919,002 $8,098,188 0%
News See All